Search results
Novartis' (NVS) Oncology Drugs Get Approval for Label Expansion
Zacks via Yahoo Finance· 2 years agoNovartis NVS has announced that the FDA granted accelerated approval to the combination of Tafinlar...
FDA Approves Pfizer's (PFE) Braftovi + Mektovi for Lung Cancer
Zacks via Yahoo Finance· 7 months agoPfizer PFE announced that the FDA had approved its supplemental new drug applications (sNDAs)...
FDA Gives Approval For Novartis' Tafinlar + Mekinist Broadens BRAF/MEK Cancer Combo Use
Benzinga via Yahoo Finance· 2 years agoThe FDA granted accelerated approval to Novartis AG's (NYSE: NVS) pairing of Tafinlar and Mekinist...
Pfizer (PFE) Gets FDA Acceptance for Braftovi + Mektovi sNDAs
Zacks via Yahoo Finance· 1 year agoPfizer PFE announced that the FDA has accepted its supplemental new drug applications (sNDAs)...
New targeted treatment approved for children with brain cancer
PA Media: Science via Yahoo News· 2 weeks agoA new targeted treatment which could transform the lives of children with brain tumours has been...
Pharma Stock Roundup: LLY Meets IBD Study Goal, PFE, MRK Give Cancer Pipeline Updates
Zacks via Yahoo Finance· 7 months agoThis week, Eli Lilly’s LLY pipeline candidate, mirikizumab, met the main goals in a late-stage study...
Novartis wins U.S. approval for targeted cancer drug combination
Reuters via Yahoo News· 2 years agoA targeted oral drug combination by Novartis won U.S. approval for use in a wide range of advanced...
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
Zacks via Yahoo Finance· 1 month agoQIAGEN N.V. QGEN recently announced a sequence of new products to augment cancer research further...
The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – April 10, 2023 – Zacks.com announces the list of stocks featured...
FDA Approves Novartis' Tafinlar + Mekinist For Pediatric Brain Cancer With Certain Mutations
Benzinga via Yahoo Finance· 1 year agohttps://cdn.benzinga.com/files/images/story/2023/03/17/nvs.png?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 The FDA has approved Novartis AG's (NYSE: NVS) Tafinlar (dabrafenib) + Mekinist ...